Formycon And Bioeq Offer Ranibizumab Update

Partners Set Out Next Steps For Lucentis Biosimilar In US And EU

 
• By David Wallace
  
US EU Flags Gears Europe
The FYB201 ranibizumab biosimilar is in the works for the US and Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products